It's time for 3 insightful webinars at Toxys! 1️⃣ On 26 September: We will introduce the miniaturized version of the ReproTracker assay that combines higher throughput, reduced compound requirement, and faster results. https://lnkd.in/d5JpX44d 2️⃣ On 10 October: We will illustrate how ToxProfiler can be applied to generate a toxicological signature for compounds and demonstrate the applications of ToxProfiler-derived points of departures and human cMAX information for the classification of DILI. https://lnkd.in/d8U7kZxt 3️⃣ On 24 October: We will tell all about MutaTracker, the latest addition to our genetic toxicology portfolio that seamlessly combines ToxTracker and single-molecule mutation sequencing (SMM-seq) for predicting mutagenic and genetic MoA. https://lnkd.in/dQ9w8WxE Will you join us in these webinars?
Toxys Inc.
Research Services
New York, NY 104 followers
Genetic, developmental, and investigative toxicology with New Approach Methodologies (NAMs)
About us
Toxys is global leading expert that develops and offers a broad spectrum of unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Toxys Inc. is a subsidiary in the US with a sales office in New York (NY) and a production facility in Gaithersburg (MD) that focuses on serving clients in North America. We are experts in the fields of genotoxicity, developmental toxicology and mechanistic toxicity testing. We develop assays with the focus on understanding the mode-of-action of toxic compounds. Our ToxTracker® assay accurately identifies direct and indirect genotoxic compounds, ReproTracker® detects developmental toxicity that occurs when differentiating human stem cells, and ToxProfiler™ provides a broad toxicity profile of compounds using high content imaging. Our unique assays provide relevant information to avoid compounds failing at a late stage of development due to unforeseen toxicity. We aim to bring information to our customers that is essential to make informed decisions on which compounds to progress in drug/compound development, thereby contributing to the development of better medicines and products while reducing the need for animal testing. Every novel chemical that is developed in the pharmaceutical, chemical, cosmetics or food industries must be rigorously tested for human health hazards before being considered safe for marketing. Current in vitro toxicity tests, which are an essential part of compound risk assessment, often suffer from a low predictive value and lack the possibility to provide insight into the mode-of-action of toxic compounds. To address these unmet needs, Toxys offers a diverse portfolio of in vitro assays that provide mode-of-action information on toxic compounds and provide information relevant to human health. The assays are used for early compound screening, follow-up testing, mode-of-action assessment, potency ranking and chemical read-across and are particular
- Website
-
https://toxys.com/
External link for Toxys Inc.
- Industry
- Research Services
- Company size
- 2-10 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2021
- Specialties
- Genotoxicity testing, Mechanism-based toxicology, DNA damage response, Mammalian reporter assays, Stem cells, BAC technologies, New Approach Methods, Developmental Toxicity Assay, Mode-of-action information, and Mechanistic insight of toxicity
Locations
-
Primary
228 E 45th St
Suite 9E
New York, NY 10017, US
Employees at Toxys Inc.
Updates
-
Toxys Inc. reposted this
🎉 We are thrilled to announce our launch of MutaTracker, a unique mammalian in vitro assay that predicts mutagenicity and genotoxicity of compounds and chemicals with an unmatched accuracy and sensitivity! MutaTracker combines ToxTracker and single-molecule mutation sequencing in a single workflow, which we offer in partnership with Mutagentech Visit the link below to read our press release and learn more about MutaTracker. https://lnkd.in/dvMr7f5c #MutaTracker #mutagenicity #genotoxicity #ngs
-
Toxys Inc. reposted this
Last week IIVS accomplished two firsts: We held our first ToxTracker workshop, and our first hybrid hands-on/virtual workshop. We welcomed participants in the lab and online to learn more about the ToxTracker ACE Genotoxicity assay, developed by Toxys Inc. and offered in our laboratory. Presentions were given by IIVS experts Carlos I. Rodríguez and Vivek Patel as well as guests Stephanie Kellum, Ashley Allemang, Stefan Pfuhler, and Dan Roberts. Many thanks to all who joined. Join our mailing list to learn about future educational events: https://lnkd.in/gPTpXyRs.
-
Join Toxys Inc Director BD & Sales Dan R. and Toxys CEO Giel Hendriks at the Environmental Mutagenesis and Genomics Society Annual Meeting 2024 in Palm Springs 7-11 September! You can find an overview of our presentations below and at https://lnkd.in/dRaDrcvG
-
Toxys Inc. reposted this
Have you read our case study where we tested 68 chemicals with ToxTracker and compared the results to in vitro and in vivo micronucleus assay data? Head over to our blog for the full article as well as a PDF downloadable. https://lnkd.in/dFfMB_Nx #toxtracker #genotoxicity #nams
-
Toxys Inc. reposted this
Interested in learning more about the ToxTracker assay? This assay assesses a variety of potential mechanisms for genetic toxicity effects. We are holding a hands-on workshop next month--register now to get an in-depth look at the assay and how it can be used. 🗓 August 15-16, 2024 Gaithersburg, Md Virtual* and in-person spots are available, and complimentary registration for regulators. Contact us with any questions. Register here: https://lnkd.in/dU5Vhw8M *Virtual participation will be lectures only, not the lab portions of the workshop.
-
Toxys Inc. reposted this
Our CEO Giel Hendriks and CBO Paula van Rossum recently joined the online seminar facilitated by Masashi MATSUNAGA, Ph.D. CEO of Biospire and supporter of Life Science Innovation Network Japan (LINK-J) to talk about our NAMs portfolio. The recording is now available on YouTube, which you can freely access here (partly Japanese) 👉 https://lnkd.in/d3hkJnXQ Did you know that Toxys also has a website in Japanese? You can check it out here 👉 https://lnkd.in/dg9gKBJC
-
Organized by IIVS, below ToxTracker workshop that will take place in Gaithersburg is a great opportunity to get hands on experience on this unique in vitro #genotoxicity assay. If you would like to save your spot, head over to the link below for more information and to register!
📅 Register now for an in-depth workshop focusing on the ToxTracker assay, developed by Toxys Inc. and offered by IIVS. Dates: August 15-16, 2024 Location: IIVS HQ, Gaithersburg, Md. Participants will be able to view and participate in the conduct of the assay in the lab and hear from IIVS and guest speakers about the science behind the assay, its applications, and regulatory status. Find out more: https://lnkd.in/g-6TFN3u Register: https://lnkd.in/gFekUpbF